Board of Directors
Mr David Ruschena
David Ruschena is currently General Counsel at Alfred Health. He has more than 20 years’ experience in health, including in private practice, at the Victorian Department of Health and at the Federal Court of Australia. He was formerly a management consultant working in corporate strategy and health regulation, with projects in corporate reorganisation and consumer protection in the NDIS.
Mr Ruschena received his PhD from the University of Melbourne in public health regulation.
Dr Chris Smith
Chris Smith is an Investment Manager at Brandon Capital Partners with over 15 years’ scientific and commercial experience in the pharmaceutical industry. He was formerly a Business Development Manager with CSL Ltd and has experience with both in and out-licensing of therapeutic drugs and R&D enabling platforms.
Dr Smith received his PhD at the Walter and Eliza Hall Institute, Australia and his MBA (specialising in innovation and entrepreneurship) from the University of Cambridge, U.K.
Mr Thomas Ulmer
Thomas Ulmer is a Senior Financial Executive with almost 20 years of experience directing all financial matters. He was formerly the Chief Financial Officer of Immatics N.V., where he was instrumental in leading the company to its NASDAQ listing. Previous leadership positions include Chief Financial Officer of Allergopharma and VP Business Planning & Analysis for the Merck Group.
Mr Ulmer received his MBA from University of Giessen, Germany and is a Fellow member of CPA Australia.